Initial results show ProvenRecovery program cut hospital stays in half, drove $1.5 million in savings, and contributed to 18 percent reduction in opioid use across organization
Initial results show ProvenRecovery program cut hospital stays in half, drove $1.5 million in savings, and contributed to 18 percent reduction in opioid use across organization
DANVILLE, Pa., Nov. 15, 2018 /PRNewswire/ -- Today, Geisinger announces the launch of ProvenRecovery, a surgical redesign program aimed at expediting healing, improving pain management and reducing opioid use. The program will be implemented across 42 surgical procedures impacting approximately 15,000 surgery cases annually, with the goal of reaching 100 surgical specialties by the end of 2019.
ProvenRecovery combines the best practices of Geisinger’s ProvenCare® program in cardiac, bariatric, spine and joint surgical care, along with industry best practices in optimizing patients for elective surgeries. The ProvenRecovery pilot, which began in June 2017, has driven an 18 percent decrease in opioid usage across the organization. During the pilot, neurosurgery and colorectal surgery patients saw their hospital stays cut in half. Earlier discharges accounted for an average savings of $4,556 per case for colorectal surgery patients.
“In my 35 years in surgery, this is the innovation with the greatest potential to improve the patient experience, save lives, reduce complications and be less disruptive to patients,” said Neil Martin, MD, Geisinger’s chief quality officer and chair of Geisinger’s neuroscience institute. “With ProvenRecovery, we are empowering patients to be healthier before surgery, leading to fewer surgical complications and patients returning to their lives sooner.”
ProvenRecovery focuses on three key measures to empower patients be healthier before and after surgery:
- Proper nutrition - During a pre-surgery consultation, patients receive a kit, including care instructions, mobility instructions and immunonutrition drinks. Unlike traditional fasting immediately preceding surgery, the fortified drinks are designed to get patients to a proper nutrition level before surgery to help reduce infection, accelerate healing after surgery and account for nutrition gaps in the average American diet.
- Appropriate pain management – Surgery through this approach is opioid avoiding, and in many cases opioid free. During surgery, a patient’s pain is controlled by specifically targeting the surgical area. Known as multi-modal pain management, this technique allows for effective pain control of just one area. A combination of non-opioid medications is used, depending on the surgery, such as local anesthesia, acetaminophen, ibuprofen, gabapentin, ketamine and lidocaine.
- Mobility post-surgery - When a patient wakes up in the recovery room, they are encouraged and assisted in early mobility in and around the bed. This mobility helps to speed up the recovery process, getting them back home and back to their lives faster.
“Since the early 90s, Geisinger has been pioneering patient-centric programs that revolutionize care design and management, paving the way for the industry in the move to value,” said Jaewon Ryu, MD, JD, Geisinger’s interim president and chief executive officer. “ProvenRecovery is a natural evolution of these efforts, building on the successes of our ProvenCare program. By getting patients healthier and out of the hospital sooner, not only are we improving lives, we’re also reducing overall costs of care.”
ProvenRecovery is the latest innovation from Geisinger, building on the organization’s work in genomic medicine with the MyCode® Community Health Initiative research, and addressing food insecurity and diabetes through its Fresh Food Farmacy®.
About Geisinger
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs including the ProvenCare® best-practice approach to maximize quality, safety and value; ProvenHealth Navigator® advanced medical home; Springboard Health® population health program to improve the health of an entire community; ProvenExperience™ to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.
View original content:http://www.prnewswire.com/news-releases/geisinger-launches-surgical-redesign-program-to-reduce-opioid-use-and-improve-patient-experience-300751278.html
SOURCE Geisinger
